AMGN Jul 2023 220.000 put

OPR - OPR Prezzo differito. Valuta in USD.
5,85
-0,64 (-9,86%)
Al 12:51PM EDT. Mercato aperto.
Il grafico dei titoli non è supportato dal tuo browser attuale
Chiusura precedente6,49
Aperto6,55
Denaro5,85
Lettera6,00
Prezzo d'esercizio220,00
Scadenza2023-07-21
Min-Max giorno5,80 - 6,55
Contratto - Min-MaxN/D
Volume17
Open Interest392
  • GlobeNewswire

    Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease

    Collaboration Brings Together TScan’s Proprietary Target Discovery Platform and Amgen’s Inflammation Therapeutic Expertise and Research Capabilities TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million THOUSAND OAKS, Calif. and WALTHAM, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and TScan Therapeutics, Inc. (NASDAQ:TCRX), today announced a multi-year collaboration that will use TScan’s proprietary target discovery